Genomic Health, Inc. (GHDX) Tops Q1 EPS by 5c
Tweet Send to a FriendGet Alerts GHDX Hot Sheet
Price: $37.21 --0%
EPS Growth %: -250.0%
Financial Fact:
Income (loss) before income taxes: -830K
Today's EPS Names:
ZLC, TOL, TGT, More
EPS Growth %: -250.0%
Financial Fact:
Income (loss) before income taxes: -830K
Today's EPS Names:
ZLC, TOL, TGT, More
Trade GHDX Now!
Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.58 million versus the consensus estimate of $56.27 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Campbell Soup Co. (CPB) Tops Q3 EPS by 6c; Boosts FY13 Outlook
- Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
